Company Analysis

ImmuCell Corporation (ICCC)

Nasdaq: ICCC · In Vitro & In Vivo Diagnostic Substances · Portland, ME · filing with the SEC since 1995
Grade5.3
◀ Past 4.8● Present 5.8▶ Future 4.9
1 est.

Filings

241 filings since 2017 beside 93 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included
2629283432403242
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Apr 14, 2026.SEC letters: 2 in the last 36 months, the newest Apr 5, 2024.
Insider forms 93

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 13, 2026 8-K items 2.02, 9.01 Results released · Current report Nov 12, 2026
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 S-8 Employee stock plan registration
Oct 13, 2026 8-K items 2.02, 9.01 Results released · Current report Oct 12, 2026
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 17, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 11, 2026
Jun 10, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Jun 4, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 10-K/A Annual report, amended Dec 31, 2025
May 8, 2026 8-K item 1.01 Major agreement signed · Current report
Apr 24, 2026 DEF 14A Proxy statement Jun 11, 2026
Apr 14, 2026 PRE 14A Preliminary proxy statement Jun 11, 2026
Apr 14, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report Apr 7, 2026
Apr 8, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 18, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Mar 12, 2026
Mar 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 9, 2026 8-K items 5.02, 9.01 Officer or director change · Current report
Feb 2, 2026 8-K items 1.01, 5.02, 9.01 Major agreement signed; Officer or director change · Current report Jan 27, 2026
Jan 8, 2026 8-K items 2.02, 2.06, 8.01, 9.01 Results released; Write-down of assets; Other event · Current report
Dec 29, 2025 8-K items 2.06, 8.01, 9.01 Write-down of assets; Other event · Current report Dec 24, 2025
Nov 20, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 13, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Oct 29, 2025
Oct 7, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 30, 2025 8-K items 1.01, 5.02, 9.01 Major agreement signed; Officer or director change · Current report Sep 29, 2025
Aug 25, 2025 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Aug 20, 2025
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Aug 14, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 12, 2025 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Aug 7, 2025
Jul 9, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 25, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 17, 2025 8-K item 5.07 Shareholder vote · Current report Jun 12, 2025
May 14, 2025 8-K items 2.02, 9.01 Results released · Current report
May 14, 2025 10-Q Quarterly report Mar 31, 2025
Apr 24, 2025 DEF 14A Proxy statement Jun 12, 2025
40 of 241 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ICCC · research, not advice